ArticleCellular oncology (Dordrecht, Netherlands)2025

ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity.

Irene Zamora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.